Nanoparticle-integrin antagonist C16Y peptide treatment of choroidal neovascularization in rats.
about
Recent advances in protein and Peptide drug delivery: a special emphasis on polymeric nanoparticlesTransscleral sustained vasohibin-1 delivery by a novel device suppressed experimentally-induced choroidal neovascularizationThe potential of nanomedicine therapies to treat neovascular disease in the retina.Protein polymer nanoparticles engineered as chaperones protect against apoptosis in human retinal pigment epithelial cellsLong-term suppression of ocular neovascularization by intraocular injection of biodegradable polymeric particles containing a serpin-derived peptideMechanism for laser-induced neovascularization in rat choroid: accumulation of integrin α chain-positive cells and their ligands.Nanotechnology and nanotoxicology in retinopathy.Nanoengineering of therapeutics for retinal vascular disease.Dimerization of visual pigments in vivo.Drug delivery strategies for therapeutic angiogenesis and antiangiogenesis.Nanoparticles in the ocular drug delivery.Intravitreal drug delivery in retinal disease: are we out of our depth?Drug Delivery Nanoparticles: Toxicity Comparison in Retinal Pigment Epithelium and Retinal Vascular Endothelial CellsNanocarrier mediated retinal drug delivery: overcoming ocular barriers to treat posterior eye diseases.Investigation of nanoparticles using magnetic resonance imaging after intravitreal injection.Disruption of Rhodopsin Dimerization in Mouse Rod Photoreceptors by Synthetic Peptides Targeting Dimer Interface.
P2860
Q27028129-FC2F0481-21BD-4E7C-A33C-2CA564517121Q28487648-B659AD96-567D-4721-95BC-221E07AA8B01Q34220590-2070F7C7-25DC-476A-B164-EE057AEF085CQ34465338-8AB33265-C759-4FE8-8B86-310DF8C2583FQ34816580-FAD8CAB4-0805-4960-ABB6-3E093372D725Q35193788-DA623965-D1E0-4E15-B0C1-13BD51929A69Q35600266-B7FAB2B7-1942-4B75-B463-8146AFBDCCBDQ35645705-D3C4037B-3D1E-48F8-B767-177BA6B4274CQ37181919-A5CDB439-D999-4197-89A6-0DCF084547CAQ37845396-8F703545-4709-4948-9F23-0A31FAA26A6CQ38119238-084A1955-7FFD-4CCB-BE84-87A2EF72B568Q38220453-A8B8C3FD-E4EB-4459-9AEE-5F13F88903E0Q38766790-9F71B8AA-54D4-4D08-83B8-D2FD99998445Q38829320-93D78C3C-07EB-4A49-A4ED-2D65DF5BD736Q49064827-68E62516-A265-4D5D-A3A9-0002EE7B617BQ52689995-66A15469-3338-4597-A3F7-A0A84EF2B8B0
P2860
Nanoparticle-integrin antagonist C16Y peptide treatment of choroidal neovascularization in rats.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Nanoparticle-integrin antagoni ...... al neovascularization in rats.
@ast
Nanoparticle-integrin antagoni ...... al neovascularization in rats.
@en
Nanoparticle-integrin antagoni ...... al neovascularization in rats.
@nl
type
label
Nanoparticle-integrin antagoni ...... al neovascularization in rats.
@ast
Nanoparticle-integrin antagoni ...... al neovascularization in rats.
@en
Nanoparticle-integrin antagoni ...... al neovascularization in rats.
@nl
prefLabel
Nanoparticle-integrin antagoni ...... al neovascularization in rats.
@ast
Nanoparticle-integrin antagoni ...... al neovascularization in rats.
@en
Nanoparticle-integrin antagoni ...... al neovascularization in rats.
@nl
P1476
Nanoparticle-integrin antagoni ...... al neovascularization in rats.
@en
P2093
Hyuncheol Kim
Karl G Csaky
P304
P356
10.1016/J.JCONREL.2009.10.031
P407
P577
2009-11-04T00:00:00Z